Free preview

Alpha-1 Antitrypsin Deficiency

Overview and clinical definition are open. Full Step 1 details unlock with a plan.

For the why behind the fact

Use this page to connect what you are memorizing.

Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.

Overview


Plain-Language Overview

Alpha-1 Antitrypsin Deficiency is a genetic condition that mainly affects the lungs and liver. It occurs when the body does not produce enough of a protein called alpha-1 antitrypsin, which protects the lungs from damage caused by enzymes. Without enough of this protein, harmful enzymes can attack lung tissue, leading to breathing problems like emphysema. The liver can also be affected because abnormal alpha-1 antitrypsin proteins can build up and cause liver damage. People with this condition may experience symptoms such as shortness of breath, wheezing, and chronic cough. It is important to understand that this condition is inherited and can vary in severity among individuals.

Clinical Definition

Alpha-1 antitrypsin deficiency (AATD) is a SERPINA1-associated, autosomal codominant disorder. Reduced functional circulating AAT permits neutrophil-elastase injury, classically causing basilar panacinar emphysema. In contrast, liver disease results from retained abnormal protein, especially Z polymers in hepatocytes, and may cause neonatal cholestasis, cirrhosis or hepatocellular carcinoma. PI*ZZ is a common severe genotype; null/null causes profound deficiency and lung risk without retained-protein liver disease. Organ involvement and penetrance vary.

Clinical Presentation


Diagnostic Workup


Pathophysiology


Treatments


Prevention


Outcome & Complications


Differential Diagnoses